FLI1 and Bloom syndrome: In the dermis, the proportion of CD103+ DCs was significantly increased, while the proportions of CD103−CD11b+ DCs and CD103−CD11b− DCs were unaltered in BLM-treated Fli1+/− mice compared with BLM-treated WT mice (Fig. 2).